lysosomal storage disorders
| 3 min read
Protalix and Chiesi share encouraging data from Phase 3 trial evaluating pegunigalsidase alfa in Fabry disease
| 2 min read
EMA grants Orphan Drug designation to JR-171 for the treatment of mucopolysaccharidosis type I
Page 1 of 1 - 2 Total Items
